Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
DGX
DXCM
Add up to 3 more stocks
DGX
Quest Diagnostics Incorporated
+3.95%
$247.29+9.40Delayed quote: Sep 15, 2026, 4:00 PM EDT
Market Cap
$27.29B
52W Range
$171.18 - $247.19
DXCM
DexCom, Inc.
+2.09%
$86.45+1.77Delayed quote: Sep 15, 2026, 4:00 PM EDT
Market Cap
$32.62B
52W Range
$54.11 - $92.59
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 26.25 | 34.17 |
| Forward P/E | 22.10 | 32.41 |
| P/B Ratio | 3.63 | 12.44 |
| P/S Ratio | 2.36 | 6.57 |
| P/FCF Ratio | 22.37 | 23.22 |
| EV/EBITDA | 16.55 | 23.46 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 33.1% | 62.5% |
| Operating Margin | 14.1% | 22.9% |
| Net Margin | 9.2% | 20.1% |
| ROE | 14.1% | 38.1% |
| ROA | 6.3% | 15.5% |
| ROIC | 8.3% | 21.7% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.59 | 1.73 |
| Quick Ratio | 1.46 | 1.43 |
| Debt/Equity | 0.85 | 0.53 |
| Interest Coverage | 5.79 | 49.83 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 1.4% | N/A |
| Payout Ratio | 35.2% | N/A |
| Yrs of Dividend Growth | 14 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.